Cobalamin malabsorption is a hereditary canine health condition causing the body to struggle absorbing and using vitamin B12, essential for cell development and nervous system function.
This rare condition occurs when dogs' intestines lack the necessary binding receptors to process vitamin B12 properly. It is inherited and cannot be caught or developed otherwise. This can lead to symptoms such as failure to thrive, lethargy, and weight issues in affected puppies.
Because of its hereditary nature, Beagle puppies and Border Collie puppies have been identified as at-risk breeds. The Kennel Club, working alongside the British Veterinary Association, oversees a screening programme to help breeders make informed mating decisions and reduce disease spread in these breeds.
The condition is inherited through autosomal recessive genetics. This means a dog’s status can be clear, carrier, or affected based on gene pair combinations inherited from parent dogs. Affected dogs show symptoms usually well before their first birthday, sometimes as early as six weeks.
Carriers do not show symptoms but can pass the mutated gene to offspring. Responsible breeders should only mate carriers to clear dogs to prevent affected puppies while maintaining genetic diversity.
Cobalamin malabsorption is linked to mutations in genes responsible for cobalamin absorption, notably the CUBN gene in Beagles and Border Collies. Other breeds like Australian Shepherds, Giant Schnauzers, and Komondors have their own specific mutations associated with the condition, although these varieties are less common in the UK.
Breeders working with carriers should carefully plan pairings to avoid affected litters and help reduce this genetic disorder in the wider population.
A simple DNA test can determine your dog's cobalamin absorption status. Vets collect a sample via blood vial or cheek swab, which is sent to approved laboratories. Results returned are "clear," "carrier," or "affected." Results for registered Beagle and Border Collie dogs are also shared with The Kennel Club to assist breed health monitoring.
Early testing supports responsible breeding and helps affected dogs receive appropriate care, like vitamin B12 supplementation to manage symptoms effectively.
It is vital for breeders to prioritise health by using tested breeding stock. Avoiding mating two carriers or affected dogs reduces affected puppies and supports breed vitality. Transparent sharing of test results within the community furthers the collective goal of healthier dog populations.
Standard health testing, including for cobalamin malabsorption, is a key part of ethical and informed breeding programmes supported by bodies like The Kennel Club and veterinary professionals across the UK.
Yes, carriers themselves are healthy and can have healthy puppies if mated only with clear dogs.
With early diagnosis through testing, affected dogs often respond well to vitamin B12 supplementation, allowing a good quality of life.
Genetic testing is recommended for all breeding stock of at-risk breeds before mating decisions to prevent passing on this condition.
By staying informed and using dog DNA testing effectively, breeders and owners contribute to reducing hereditary diseases like cobalamin malabsorption, ensuring healthier future generations.